Trial Condition(s):
Contraception
DIU-QoL. Quality of life evaluation in Intrauterine Device users. (DIUQoL)
Bayer Identifier:
16341
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Knowledge about the impact on quality of life of women initiating IUD in the Spanish population at baseline and after 12 months of use.
Inclusion Criteria
- 18-49 years old female. - Women who is visited by a gynecology or primary care physician and starts contraception with an IUD/IUS. - Women that has not used hormonal contraception in any form in the last 3 months. - Women who have no problems listening, reading or writing. - Women who gives their written consent to participate in the study.
Exclusion Criteria
- Women who have contraindications to use IUDs. - Women with previous experience with IUDs. - Women who initiates the use of IUDs for other purposes other than contraception. - Woman who is participating in a clinical trial at the time of initiating the study.
Trial Summary
Enrollment Goal
207
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers
No
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Investigative Site Many Locations, Spain | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
DIU-QoL. Quality of life evaluation in Intrauterine Device users.
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Impact on quality of life of women initiating IUD in a Spanish population assessed by questionnaire.Timeframe: After 12 months
Secondary Outcome
- Demographic Data (Age, Place of Birth, Level of Education, Employment status, Personal marital situation, etc.) assessed by questionnaire.Timeframe: Baseline
Additional Information
Copyright © Bayer
Powered by
